Victor Manuel Calvo, MD | |
6200 Sw 73rd St # 69, South Miami, FL 33143-4679 | |
(786) 662-5465 | |
(786) 662-5334 |
Full Name | Victor Manuel Calvo |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 13 Years |
Location | 6200 Sw 73rd St # 69, South Miami, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023302908 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | ME 120962 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Seasons Hospice & Palliative Care Of Southern Flor | Miami, FL | Hospice |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
South Miami Inpatient Physicians | 2567429483 | 49 |
News Archive
Researchers at UC Riverside's Akbari lab have brought a new strain of red-eyed mutant wasps into the world.
Merck announced that the Committee for Medicinal Products for Human Use adopted a positive opinion on the pending Marketing Authorization Application for SYCREST (asenapine) sublingual tablets. The CHMP has recommended that the European Commission grant a marketing authorization for SYCREST for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. The CHMP did not support an indication for the treatment of schizophrenia.
In a brazen attempt to silence AIDS advocates' ongoing criticism of Abbott Laboratories over its recent 400% price hike on the key AIDS drug Norvir, two prominent gay publications are buckling under pressure from Abbott to refuse to run, or significantly alter, a parody advertisement created by AIDS Healthcare Foundation (AHF) that spoofs the drug giant's media spin on their unprecedented price hike on Norvir.
An experimental biomarker test developed by researchers at the University of Michigan more accurately detects prostate cancer than any other screening method currently in use, according to a study published in the February 1 issue of Cancer Research, a journal of the American Association for Cancer Research.
"Global progress in both preventing and treating HIV emphasizes the benefits of sustaining investment in HIV/AIDS over the longer term," according to a new report from the WHO, UNICEF and UNAIDS, which also "indicates that increased access to HIV services resulted in a 15 percent reduction of new infections over the past decade and a 22 percent decline in AIDS-related deaths in the last five years," a WHO press release reports.
› Verified 7 days ago
Entity Name | South Miami Inpatient Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346313194 PECOS PAC ID: 2567429483 Enrollment ID: O20041213000615 |
News Archive
Researchers at UC Riverside's Akbari lab have brought a new strain of red-eyed mutant wasps into the world.
Merck announced that the Committee for Medicinal Products for Human Use adopted a positive opinion on the pending Marketing Authorization Application for SYCREST (asenapine) sublingual tablets. The CHMP has recommended that the European Commission grant a marketing authorization for SYCREST for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. The CHMP did not support an indication for the treatment of schizophrenia.
In a brazen attempt to silence AIDS advocates' ongoing criticism of Abbott Laboratories over its recent 400% price hike on the key AIDS drug Norvir, two prominent gay publications are buckling under pressure from Abbott to refuse to run, or significantly alter, a parody advertisement created by AIDS Healthcare Foundation (AHF) that spoofs the drug giant's media spin on their unprecedented price hike on Norvir.
An experimental biomarker test developed by researchers at the University of Michigan more accurately detects prostate cancer than any other screening method currently in use, according to a study published in the February 1 issue of Cancer Research, a journal of the American Association for Cancer Research.
"Global progress in both preventing and treating HIV emphasizes the benefits of sustaining investment in HIV/AIDS over the longer term," according to a new report from the WHO, UNICEF and UNAIDS, which also "indicates that increased access to HIV services resulted in a 15 percent reduction of new infections over the past decade and a 22 percent decline in AIDS-related deaths in the last five years," a WHO press release reports.
› Verified 7 days ago
Entity Name | Seasons Medical Group Of Florida Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710238381 PECOS PAC ID: 0941451314 Enrollment ID: O20121112000411 |
News Archive
Researchers at UC Riverside's Akbari lab have brought a new strain of red-eyed mutant wasps into the world.
Merck announced that the Committee for Medicinal Products for Human Use adopted a positive opinion on the pending Marketing Authorization Application for SYCREST (asenapine) sublingual tablets. The CHMP has recommended that the European Commission grant a marketing authorization for SYCREST for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. The CHMP did not support an indication for the treatment of schizophrenia.
In a brazen attempt to silence AIDS advocates' ongoing criticism of Abbott Laboratories over its recent 400% price hike on the key AIDS drug Norvir, two prominent gay publications are buckling under pressure from Abbott to refuse to run, or significantly alter, a parody advertisement created by AIDS Healthcare Foundation (AHF) that spoofs the drug giant's media spin on their unprecedented price hike on Norvir.
An experimental biomarker test developed by researchers at the University of Michigan more accurately detects prostate cancer than any other screening method currently in use, according to a study published in the February 1 issue of Cancer Research, a journal of the American Association for Cancer Research.
"Global progress in both preventing and treating HIV emphasizes the benefits of sustaining investment in HIV/AIDS over the longer term," according to a new report from the WHO, UNICEF and UNAIDS, which also "indicates that increased access to HIV services resulted in a 15 percent reduction of new infections over the past decade and a 22 percent decline in AIDS-related deaths in the last five years," a WHO press release reports.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Victor Manuel Calvo, MD 6200 Sw 73rd St # 69, South Miami, FL 33143-4679 Ph: (786) 662-5465 | Victor Manuel Calvo, MD 6200 Sw 73rd St # 69, South Miami, FL 33143-4679 Ph: (786) 662-5465 |
News Archive
Researchers at UC Riverside's Akbari lab have brought a new strain of red-eyed mutant wasps into the world.
Merck announced that the Committee for Medicinal Products for Human Use adopted a positive opinion on the pending Marketing Authorization Application for SYCREST (asenapine) sublingual tablets. The CHMP has recommended that the European Commission grant a marketing authorization for SYCREST for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. The CHMP did not support an indication for the treatment of schizophrenia.
In a brazen attempt to silence AIDS advocates' ongoing criticism of Abbott Laboratories over its recent 400% price hike on the key AIDS drug Norvir, two prominent gay publications are buckling under pressure from Abbott to refuse to run, or significantly alter, a parody advertisement created by AIDS Healthcare Foundation (AHF) that spoofs the drug giant's media spin on their unprecedented price hike on Norvir.
An experimental biomarker test developed by researchers at the University of Michigan more accurately detects prostate cancer than any other screening method currently in use, according to a study published in the February 1 issue of Cancer Research, a journal of the American Association for Cancer Research.
"Global progress in both preventing and treating HIV emphasizes the benefits of sustaining investment in HIV/AIDS over the longer term," according to a new report from the WHO, UNICEF and UNAIDS, which also "indicates that increased access to HIV services resulted in a 15 percent reduction of new infections over the past decade and a 22 percent decline in AIDS-related deaths in the last five years," a WHO press release reports.
› Verified 7 days ago
Dr. Jorge Luis Cuello, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6200 Sunset Dr, Suite 401, South Miami, FL 33143 Phone: 305-666-4633 Fax: 305-487-3323 | |
Bianca Dorina Alfonso, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6141 Sunset Dr Ste 403, South Miami, FL 33143 Phone: 305-665-2300 Fax: 305-669-8966 | |
Dr. Jaskaran Kaur Purewal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7031 Sw 62nd Ave, South Miami, FL 33143 Phone: 305-558-2500 | |
Dr. Tyler Barrett Drury, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 6200 Sw 73rd St # 69, South Miami, FL 33143 Phone: 786-662-5465 Fax: 768-662-5334 | |
Dr. Rodolfo J Cepero, M.D. P.A. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6201 Sw 70th St, Suite 103, South Miami, FL 33143 Phone: 305-668-6155 Fax: 305-661-2720 | |
Dr. Francia Elena Guerrero, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6200 Sw 73rd St, Box 69, South Miami, FL 33143 Phone: 786-662-5465 Fax: 786-662-5334 |